TPLKF yields 5.92% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, TPLKF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TPLKF + PFE for your $10,000?
PVA TePla AG, together with its subsidiaries, manufactures and sells systems for the production and refinement of high-tech materials worldwide. It operates through two segments, Industrial Systems and Semiconductor Systems. The Industrial Systems division provides structural material technologies for semiconductor, aviation and aerospace, energy technology, and hard metal tools industries; and engages in the vacuum brazing, vacuum heat treatment, and diffusion bonding activities. The Semiconductor Systems division offers crystal growing systems, including silicon wafer technologies for microelectronics and silicon carbide wafer technologies for high-performance electronics; metrology systems comprising technologies for non-destructive quality control of wafers, semiconductor parts, and high-tech industrial material; and plasma systems, such as production technologies for micro-electronic mechanical systems and high-brightness light-emitting diodes, as well as technologies for the fabrication of ultrathin wafers. The company is headquartered in Wettenberg, Germany.
Full TPLKF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.